Many people have a bleeding disorder and don't know it, but the Western Pennsylvania Bleeding Disorders Foundation is working to help people recognize the signs and get support. The foundation helps ...
Nine-year follow-up of gene therapy in haemophilia B confirms long-term safety and reduced bleeding, though full capsid ...
Hereditary hemorrhagic telangiectasia (HHT) is the second most common inherited bleeding disorder worldwide, affecting one in 3,800 persons. HHT's hallmark symptom is chronic nosebleeds, which often ...
Nursing-led remote evaluation improved triage, risk identification, and multidisciplinary preparedness in adolescents with ...
COPENHAGEN, Denmark and CAMBRIDGE, Mass., June 24, 2025 /PRNewswire/ -- Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results